Featured Research

from universities, journals, and other organizations

Liver parasite lacks key genes for fatty acid synthesis: Genome sequencing of Clonorchis sinensis

Date:
October 24, 2011
Source:
BioMed Central
Summary:
The human liver fluke Clonorchis sinensis affects more than 35 million people in South East Asia and 15 million in China. The complete genome sequence the genome of C. sinensis has provided insight into the biochemical pathways available to the fluke and shows that they are lacking enzymes required for fatty acid biosynthesis.

The human liver fluke Clonorchis sinensis affects more than 35 million people in South East Asia and 15 million in China. Infection by this parasite causes clonorchiasis. Repeated or chronic infection can lead to serious disease of the liver, gall bladder or bile ducts, including the frequently fatal bile duct cancer -- cholangiocarcinoma (CCA). The complete genome sequence the genome of C. sinensis, published in BioMed Central's open access journal Genome Biology, has provided insight into the biochemical pathways available to the fluke and shows that they are lacking enzymes required for fatty acid biosynthesis.

C. sinensis has a complex lifestyle. The eggs float in fresh water until eaten by snail. Once inside the snail they develop and grow into a free swimming stage. These burrow out of the snail and into a fish where the coat themselves in an acid resistant covering. Humans and other mammals are infected by the parasite by eating uncooked fish. Once in the small intestine the flukes migrate to the bile ducts in the liver where they live out their adult lives.

Over 16,250 genes were found within the 516Mb genome (the human genome has about 23,000 genes over 3Gb of DNA). Genes were found corresponding to genes for energy metabolism, both aerobic (used by the juveniles) and anaerobic (used by the adults). While the genes coding for proteins needed for fatty acid metabolism were all present, key enzymes were missing from fatty acid synthesis.

Prof Xinbing Yu, who led the team which performed this work, explained that "Two other liver flukes S. japonicum and S. mansoni are also missing these enzymes. This means that liver flukes evolved to use their host's fatty acids before the species separated." Prof Xinbing concludes: "Genomic information is not only able to help us understand evolution but the sequence of C. sinensis is helping us understand liver fluke biology. This in turn will help find new ways of controlling diseases caused by this parasite or provide new targets for making a vaccine."


Story Source:

The above story is based on materials provided by BioMed Central. Note: Materials may be edited for content and length.


Journal Reference:

  1. Xiaoyun Wang, Wenjun Chen, Yan Huang, Jiufeng Sun, Jingtao Men, Hailiang Liu, Fang Luo, Lei Guo, Xiaoli Lv, Chuanhuan Deng, Chenhui Zhou, Yongxiu Fan, Xuerong Li, Lisi Huang, Yue Hu, Chi Liang, Xuchu Hu, Jin Xu, Xinbing Yu. The draft genome of the carcinogenic human liver fluke Clonorchis sinensis. Genome Biology, 2011; 12: R107 DOI: 10.1186/gb-2011-12-10-r107

Cite This Page:

BioMed Central. "Liver parasite lacks key genes for fatty acid synthesis: Genome sequencing of Clonorchis sinensis." ScienceDaily. ScienceDaily, 24 October 2011. <www.sciencedaily.com/releases/2011/10/111024084717.htm>.
BioMed Central. (2011, October 24). Liver parasite lacks key genes for fatty acid synthesis: Genome sequencing of Clonorchis sinensis. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/10/111024084717.htm
BioMed Central. "Liver parasite lacks key genes for fatty acid synthesis: Genome sequencing of Clonorchis sinensis." ScienceDaily. www.sciencedaily.com/releases/2011/10/111024084717.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins